K2M Group Holdings Inc (NASDAQ:KTWO) has earned a consensus recommendation of “Buy” from the fourteen analysts that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $24.44.

Several equities research analysts have weighed in on the company. Zacks Investment Research upgraded K2M Group from a “sell” rating to a “hold” rating in a report on Thursday, January 25th. BidaskClub upgraded K2M Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 10th. Barclays restated a “buy” rating and set a $25.00 price objective on shares of K2M Group in a research note on Tuesday, January 9th. Needham & Company LLC upped their price objective on K2M Group from $20.00 to $23.00 and gave the stock a “buy” rating in a research note on Tuesday, January 9th. Finally, Wells Fargo & Co cut K2M Group from an “outperform” rating to a “market perform” rating and set a $23.00 price objective for the company. in a research note on Monday, December 4th.

Several hedge funds and other institutional investors have recently modified their holdings of KTWO. Elk Creek Partners LLC purchased a new stake in shares of K2M Group during the 3rd quarter worth $7,836,000. Gabelli Funds LLC lifted its stake in shares of K2M Group by 1,587.1% during the 4th quarter. Gabelli Funds LLC now owns 308,733 shares of the medical device company’s stock worth $5,557,000 after purchasing an additional 290,433 shares during the last quarter. State Street Corp lifted its stake in shares of K2M Group by 39.8% during the 2nd quarter. State Street Corp now owns 713,257 shares of the medical device company’s stock worth $17,378,000 after purchasing an additional 203,067 shares during the last quarter. Gamco Investors INC. ET AL increased its position in K2M Group by 458.4% during the 4th quarter. Gamco Investors INC. ET AL now owns 223,375 shares of the medical device company’s stock valued at $4,021,000 after buying an additional 183,375 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in K2M Group by 83.0% during the 3rd quarter. Bank of New York Mellon Corp now owns 380,637 shares of the medical device company’s stock valued at $8,073,000 after buying an additional 172,650 shares in the last quarter. Hedge funds and other institutional investors own 98.84% of the company’s stock.

Shares of K2M Group (KTWO) traded up $0.07 during mid-day trading on Friday, hitting $19.53. The company’s stock had a trading volume of 198,226 shares, compared to its average volume of 307,689. K2M Group has a twelve month low of $16.44 and a twelve month high of $25.99. The stock has a market cap of $893.00, a PE ratio of -20.24 and a beta of 1.47. The company has a quick ratio of 1.67, a current ratio of 3.06 and a debt-to-equity ratio of 0.29.

ILLEGAL ACTIVITY WARNING: This report was first reported by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at https://www.dailypolitical.com/2018/02/06/analysts-set-k2m-group-holdings-inc-ktwo-pt-at-24-44.html.

About K2M Group

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.